Barrex Pharmaceuticals Private Limited
About Barrex Pharmaceuticals Private Limited
Data last updated:
Barrex Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 21 November 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21000MH2023PTC414138.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹20,000. It is led by directors Khaja Nasim Sayyad and Suhaila Khaja Sayyad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 12, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.43 Lakh. For the same year it recorded a net profit of ₹21,102 (net margin 2.8%) and EBITDA of ₹21,102 (EBITDA margin 2.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Barrex Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressKrishna Residency Flat No. 301 Plot No 99E Sector 12E, Ges Koparkhairane Washi, Thane, Maharashtra, India – 400709
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Barrex Pharmaceuticals Private Limited
FY 2025 filings availableBarrex Pharmaceuticals Private Limited reported revenue of ₹7.43 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹21,102 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹21,102 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.8% | |
| Net Profit Margin | 2.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Barrex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Barrex Pharmaceuticals Private Limited
Barrex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khaja Nasim Sayyad | Director | 21 Nov 2023 | 2 Years 11 Months | Current |
| Suhaila Khaja Sayyad | Director | 21 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Barrex Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wellisto Pharmaceuticals Private Limited | ₹7.49 Lakh (FY 2025) | 18.0% | Pune, Maharashtra, India | |||
| Healthedge Pharmaceuticals Private Limited | ₹7.49 Lakh (FY 2025) | -7.0% | Ahmedabad, Gujarat, India | |||
| Aristocrat Pharmaceuticals Private Limited | ₹7.44 Lakh (FY 2024) | -35.0% | Gurugram, Haryana, India | |||
| Surat Pharmaceuticals Private Limited | ₹7.44 Lakh (FY 2025) | 95.0% | Bhilai, Chhattisgarh, India | |||
| Alger Pharmaceuticals Private Limited | ₹7.43 Lakh (FY 2025) | Bangalore, Karnataka, India | ||||
| Barrex Pharmaceuticals Private Limitedthis company | ₹7.43 Lakh (FY 2025) | ₹21,102 | 2.8% | Thane, Maharashtra, India | ||
| Angaj Pharmaceuticals Private Limited | ₹7.4 Lakh (FY 2025) | 92.0% | Sangli, Maharashtra, India | |||
| Shellcure Pharmaceuticals Private Limited | ₹7.4 Lakh (FY 2020) | -7.0% | Pune, Maharashtra, India | |||
| Asbed Pharmaceuticals Private Limited | ₹7.39 Lakh (FY 2025) | 7.0% | Maninagar, Gujarat, India | |||
| Triroz Pharmaceuticals Private Limited | ₹7.39 Lakh (FY 2024) | 118.0% | Pune, Maharashtra, India | |||
| Marselus Pharmaceuticals Private Limited | ₹7.38 Lakh (FY 2025) | 380.0% | D B Nagr, West Bengal, India |
To see the full peer comparison of Barrex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Barrex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Barrex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Barrex Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Barrex Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Khaja Nasim Sayyad was appointed as Director on 21 Nov 2023.
Frequently asked questions
Barrex Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 21 November 2023 (3+ years old) and is registered under CIN U21000MH2023PTC414138.
Barrex Pharmaceuticals has 2 current directors:
- Khaja Nasim Sayyad - Director
- Suhaila Khaja Sayyad - Director
The latest financial statements of Barrex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Barrex Pharmaceuticals is U21000MH2023PTC414138. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Barrex Pharmaceuticals was incorporated on 21 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Barrex Pharmaceuticals by revenue are Wellisto Pharmaceuticals Private Limited, Healthedge Pharmaceuticals Private Limited, Aristocrat Pharmaceuticals Private Limited, Surat Pharmaceuticals Private Limited, Alger Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Khaja Nasim Sayyad was appointed as Director on 21 Nov 2023. Suhaila Khaja Sayyad was appointed as Director on 21 Nov 2023.
The registered office of Barrex Pharmaceuticals is at Krishna Residency Flat No. 301 Plot No 99E Sector 12E, Ges Koparkhairane Washi, Thane, Maharashtra, India – 400709.
Barrex Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
The compliance status of Barrex Pharmaceuticals is compliant as of 16 September 2026. The company is actively filing with the Registrar of Companies.
Barrex Pharmaceuticals can be reached at its registered office: Krishna Residency Flat No. 301 Plot No 99E Sector 12E, Ges Koparkhairane Washi, Thane, Maharashtra, India – 400709.